ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

AMGN Amgen Inc

269.98
0.60 (0.22%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Amgen Inc AMGN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.60 0.22% 269.98 23:00:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
265.72 265.72 271.68 269.98 269.38
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202408:00PRNUSAMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION..
16/4/202416:26PRNUSAMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
09/3/202411:20PRNUSAMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD..
08/3/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:00PRNUSAMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
29/2/202415:00PRNUSAMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE..
26/2/202408:00PRNUSAMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN..
19/2/202415:00PRNUSAMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
14/2/202415:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/2/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:00PRNUSAMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE..
07/2/202404:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
06/2/202416:05IHMARKETNEWSU.S. Stocks Finish Choppy Trading Day Modestly Higher
06/2/202415:20EDGAR2Form 8-K - Current report
06/2/202415:01PRNUSAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL..
06/2/202405:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
02/2/202415:25IHMARKETNEWSU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon..
01/2/202415:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR..
29/1/202404:00PRNUSdeCODE genetics: A sequence variant that increases risk of..
17/1/202405:33IHMARKETNEWSWall Street Highlights: Tesla Cuts Prices in Germany,..
10/1/202409:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
10/1/202407:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
10/1/202407:45IHNWGLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
03/1/202415:00PRNUSAMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE..
02/1/202410:42DJNAmgen On Pace for Record High Close -- Data Talk
26/12/202308:00PRNUSAMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS®..
19/12/202319:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/12/202308:53DJNAmgen Names James Bradner Chief Scientific Officer
14/12/202308:16EDGAR2Form 8-K - Current report
14/12/202308:00PRNUSAMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE..
14/12/202304:00PRNUSAMGEN TO SPONSOR THE IRISH OPEN
13/12/202315:40DJNAmgen Gets FDA Priority Review For Lung Cancer Treatment
13/12/202315:00PRNUSFDA Grants Priority Review to Amgen's Tarlatamab Application..
13/12/202305:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
12/12/202315:41DJNAmgen Raises Dividend 5.6% To $2.25 A Share
12/12/202315:00PRNUSAMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO..
08/12/202308:00PRNUSAMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
04/12/202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202318:40EDGAR2Form 144 - Report of proposed sale of securities
29/11/202319:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202315:00PRNUSAMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE

Su Consulta Reciente

Delayed Upgrade Clock